Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
Pfs25 is a transmission-blocking vaccine candidate for Plasmodium. Here, McLeod et al. analyze the antibody response to Pfs25 in sera from a clinical trial evaluating a Pfs25 vaccine candidate, identify a potent transmission-blocking antibody and determine recognized epitopes on Pfs25.
Saved in:
Main Authors: | Brandon McLeod, Kazutoyo Miura, Stephen W. Scally, Alexandre Bosch, Ngan Nguyen, Hanjun Shin, Dongkyoon Kim, Wayne Volkmuth, Sebastian Rämisch, Jessica A. Chichester, Stephen Streatfield, Colleen Woods, William R. Schief, Daniel Emerling, C. Richter King, Jean-Philippe Julien |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/67758bcac9e4447fab4577c5f6b5c7a0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
by: Stephen W. Scally, et al.
Published: (2017) -
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45
by: Prasun Kundu, et al.
Published: (2018) -
A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria
by: Tarlan Mamedov, et al.
Published: (2019) -
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
by: Frank Lennartz, et al.
Published: (2018) -
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
by: Yimin Wu, et al.
Published: (2008)